文献速递精神分裂症与精神病性障碍心境障碍焦虑、强迫与应激相关障碍

精神分裂症多基因风险评分在四个医疗系统中的外显率与多效性

Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients Across Four Health Care Systems.
PubMed 文献 · Am J Psychiatry · 2019-08-16

该研究利用四个医疗系统106,160例患者的电子健康记录,评估精神分裂症多基因风险评分(PRS)的外显率与多效性。PRS与精神分裂症稳健相关(每标准差OR=1.55,95%CI=1.4,1.7),最高风险十分位者精神分裂症风险可达最低十分位者的4.6倍(95%CI=2.9,7.3)。PRS还与焦虑、心境、物质使用、神经及人格障碍、自杀行为、记忆丧失和泌尿综合征正相关,与肥胖负相关。

要点

  • 精神分裂症PRS在临床医疗系统中与精神分裂症稳健相关(每SD OR=1.55)。
  • PRS最高十分位者精神分裂症风险是最低十分位者的4.6倍(95%CI=2.9,7.3)。
  • PRS对焦虑、心境、物质使用、人格障碍及自杀行为等有多效性。

核心结论

  • 精神分裂症PRS在医疗系统中与精神分裂症稳健相关,并对相关精神障碍及其他医学综合征有多效性。
  • 结果为PRS检测在医疗系统中的未来应用提供了机会与局限性的初步指示。

研究设计与样本

  • 利用四个医疗系统106,160例患者的电子健康记录评估精神分裂症遗传风险的外显率与多效性。
  • 从汇总统计量计算精神分裂症PRS,在 phenome-wide association studies 中检验其与1,359个疾病类别的关联。
  • 通过跨站点 meta-analysis 合并效应。

主要发现

  • PRS与精神分裂症稳健相关,每标准差增加OR=1.55(95%CI=1.4,1.7)。
  • PRS最高风险十分位者精神分裂症风险是最低十分位者的4.6倍(95%CI=2.9,7.3)。
  • PRS与焦虑、心境、物质使用、神经及人格障碍、自杀行为、记忆丧失和泌尿综合征正相关。
  • PRS与肥胖负相关。

关键数值与推荐

  • 精神分裂症PRS每标准差增加OR=1.55(95%CI=1.4,1.7)。
  • PRS最高十分位 vs 最低十分位精神分裂症OR=4.6(95%CI=2.9,7.3)。

临床怎么用

  • 精神分裂症PRS可作为临床风险分层的候选工具,但需结合多效性评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Individuals at high risk for schizophrenia may benefit from early intervention, but few validated risk predictors are available. Genetic profiling is one approach to risk stratification that has been extensively validated in research cohorts. The authors sought to test the utility of this approach in clinical settings and to evaluate the broader health consequences of high genetic risk for schizophrenia. METHODS: The authors used electronic health records for 106,160 patients from four health care systems to evaluate the penetrance and pleiotropy of genetic risk for schizophrenia. Polygenic risk scores (PRSs) for schizophrenia were calculated from summary statistics and tested for association with 1,359 disease categories, including schizophrenia and psychosis, in phenome-wide association studies. Effects were combined through meta-analysis across sites. RESULTS: PRSs were robustly associated with schizophrenia (odds ratio per standard deviation increase in PRS, 1.55; 95% CI=1.4, 1.7), and patients in the highest risk decile of the PRS distribution had up to 4.6-fold higher odds of schizophrenia compared with those in the bottom decile (95% CI=2.9, 7.3). PRSs were also positively associated with other phenotypes, including anxiety, mood, substance use, neurological, and personality disorders, as well as suicidal behavior, memory loss, and urinary syndromes; they were inversely related to obesity. CONCLUSIONS: The study demonstrates that an available measure of genetic risk for schizophrenia is robustly associated with schizophrenia in health care settings and has pleiotropic effects on related psychiatric disorders as well as other medical syndromes. The results provide an initial indication of the opportunities and limitations that may arise with the future application of PRS testing in health care systems.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zheutlin AB, Dennis J, Karlsson Linnér R, et al. Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients Across Four Health Care Systems. Am J Psychiatry. 2019. PMID: 31416338. doi:10.1176/appi.ajp.2019.18091085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。